Oxford Genome Sciences said last week that UCB, a biopharmaceutical firm based in Belgium, has licensed its Oxford Genome Anatomy Project (OGAP) database — the first such deal for OGeS since it launched 18 months ago.

OGeS was founded by several members of Oxford GlycoSciences' proteomics team after Celltech acquired that firm in December 2003. OGeS CEO Christian Rohlff and several of his OGS colleagues acquired a suite of technology, data, and intellectual property that Celltech jettisoned at the time of the OGS acquisition [BioInform 11-24-03].

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The New York City medical examiner is overseeing an effort to identify missing persons using DNA, according to the Associated Press.

Nobel laureate Günter Blobel has died at 81, the New York Times reports.

In PNAS this week: mouse model of genetically induced emphysema, gene expression signatures of circulating melanoma cells, and more.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.

Sponsored by

This webinar will share how clinical genetics labs can integrate cytogenetics and molecular data to assess abnormalities using a single sample on a single workflow platform.